Can a common blood thinner protect critically ill kids from catheter clots?
NCT ID NCT04924322
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether enoxaparin, a blood thinner, can prevent blood clots caused by central venous catheters in critically ill children. Researchers will enroll 258 children up to 17 years old and adjust the dose based on age. The goal is to see if age affects how well the drug works, while monitoring for bleeding risks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Enoxaparin (a blood thinner, also known as Lovenox or Clexane)
- What this could lead to
- If successful, this could provide a safer, age-appropriate way to prevent dangerous blood clots from catheters in critically ill children, reducing complications.
- What could go wrong
- This is a mid-stage trial with 258 participants, so results may not apply to all children. Enoxaparin carries a risk of bleeding, which could be serious in critically ill patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VENOUS THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arkansas Children's Hospital
RECRUITINGLittle Rock, Arkansas, 72202, United States
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
-
Children's Hospital St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
-
Children's Hospital Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Children's Hospital of Illinois at OSF Saint Francis Medical Center
RECRUITINGPeoria, Illinois, 61637, United States
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Children's Hospital of Richmond
WITHDRAWNRichmond, Virginia, 23219, United States
-
Children's of Alabama
RECRUITINGBirmingham, Alabama, 35233, United States
-
Dell Children's Medical Canter
RECRUITINGAustin, Texas, 78723, United States
-
Golisano Children's Hospital
RECRUITINGRochester, New York, 14642, United States
-
Hassenfeld Children's Hospital
RECRUITINGNew York, New York, 10016, United States
-
Johns Hopkins All Children's
RECRUITINGSt. Petersburg, Florida, 33701, United States
-
Maria Fareri Children's Hospital
RECRUITINGValhalla, New York, 10595, United States
-
Nationwide Children's Hospital
WITHDRAWNColumbus, Ohio, 43205, United States
-
New York Presbyterian Hospital
RECRUITINGNew York, New York, 10065, United States
-
Penn State Hershey Children's Hospital
RECRUITINGHershey, Pennsylvania, 17033, United States
-
Stead Family Children's Hospital
RECRUITINGIowa City, Iowa, 52242, United States
-
UH Rainbow Babies & Children's Hospital
RECRUITINGCleveland, Ohio, 44106, United States
-
UTSW Medical Center; Children's Medical Center of Dallas
RECRUITINGDallas, Texas, 75235, United States
-
University of Florida -UF Health
RECRUITINGGainesville, Florida, 32610, United States
-
University of Oklahoma
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
Yale-New Haven Children's Hospital
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- DNA blood test may predict clot risk in cancer patients
- Cancer clot study halted: new drug vs standard care
- Pedaling in bed: new device aims to fight hospital weakness
- New blood thinner tested for cancer Patients' clots – study halted early
- Can a PET scan predict who will suffer chronic leg pain after a DVT?
- Massive chinese trial tests simple steps to prevent deadly clots in hospitals